Cantor Fitzgerald Reiterates Overweight Rating on Fulcrum Therapeutics (FULC)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: FULC) | Delayed: 3.76 +0.02 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $ | |||
| Open | $3.76 | 52 Week Low | $ | |||
| Day High | $3.78 | P/E | N/A | |||
| Day Low | $3.73 | EPS | $ | |||
| Volume | 599,587 | |||||
